Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 901–1,000 of 2,883
Are immunosenescent T cells really senescent?
Slaets, H., Veeningen, N., de Keizer, P. L. J., Hellings, N., & Hendrix, S. (2024) · Aging Cell · doi:10.1111/acel.14300 · Cited by 62
“Indeed, selective deletion of senescent (p16-positive) cells extends the lifespan of mice and attenuates age-related functional decline of several vital organs such as the liver and the heart (Baker et al., 2016).”
BackgroundCellular Senescence and Periodontitis: Mechanisms and Therapeutics
Chen, S., Zhou, D., Liu, O., Chen, H., Wang, Y., & Zhou, Y. (2022) · Biology · doi:10.3390/biology11101419 · Cited by 65
Richardson, M., & Richardson, D. R. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000803 · Cited by 51
Jin, J., Tao, J., Gu, X., Yu, Z., Wang, R., Zuo, G., Li, Q., Lv, X., & Miao, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-06868-8 · Cited by 47
RetractedDiverse roles of ceramide in the progression and pathogenesis of Alzheimer's disease
Chowdhury, M. R., Jin, H. K., & Bae, J.-S. (2022) · Biomedicines · doi:10.3390/biomedicines10081956 · Cited by 47
“A previous study suggested that the removal of senescent cells in aged mice elevates their lifespan and decreases the likelihood of age-related diseases, including AD [54].”
BackgroundOgrodnik, M. B., & Gladyshev, V. N. (2023) · Nature Aging · doi:10.1038/s43587-023-00447-5 · Cited by 50
Park, J. H., Lee, N. K., Lim, H. J., Ji, S. T., Kim, Y.-J., Jang, W. B., Kim, D. Y., Kang, S., Yun, J., Ha, J. S., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0374-4 · Cited by 50
Chin, A. F., Han, J., Clement, C. C., Choi, Y., Zhang, H., Browne, M., Jeon, O. H., & Elisseeff, J. H. (2023) · Aging Cell · doi:10.1111/acel.13979 · Cited by 46
The paradox of senescent-marker positive cancer cells: challenges and opportunities
O’Sullivan, E. A., Wallis, R., Mossa, F., & Bishop, C. L. (2024) · npj Aging · doi:10.1038/s41514-024-00168-y · Cited by 62
“These were developed following seminal work demonstratingthataccumulationofsenescentcellscontributestoarangeofage-relatedpathologiesandthatselectivesenescentcellclearancealleviates theseeffects 81 .”
MethodMajor depression and enhanced molecular senescence abnormalities in young and middle-aged adults
Diniz, B. S., Reynolds III, C. F., Sibille, E., Bot, M., & Penninx, B. W. J. H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0541-3 · Cited by 45
Keeping zombies alive: The ER-mitochondria Ca2+ transfer in cellular senescence
Ahumada-Castro, U., Puebla-Huerta, A., Cuevas-Espinoza, V., Lovy, A., & Cárdenas, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119099 · Cited by 47
Senescent cells limit p53 activity via multiple mechanisms to remain viable
Sturmlechner, I., Sine, C. C., Jeganathan, K. B., Zhang, C., Fierro Velasco, R. O., Baker, D. J., Li, H., & van Deursen, J. M. (2022) · Nature Communications · doi:10.1038/s41467-022-31239-x · Cited by 45
Self-citationMechanisms driving the ageing heart
Anderson, R., Richardson, G. D., & Passos, J. F. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.015 · Cited by 46
Animal and human models to understand ageing
Lees, H., Walters, H., & Cox, L. S. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.06.008 · Cited by 56
Identification of distinct and age‐dependent p16High microglia subtypes
Talma, N., Gerrits, E., Wang, B., Eggen, B. J. L., & Demaria, M. (2021) · Aging Cell · doi:10.1111/acel.13450 · Cited by 46
Senolytic therapeutics: An emerging treatment modality for osteoarthritis
Ansari, M. M., Ghosh, M., Lee, D., & Son, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102275 · Cited by 57
Jesel, L., Abbas, M., Park, S., Matsushita, K., Kindo, M. J., Hasan, H., Auger, C., Sato, C., Ohlmann, P., Mazzucotelli, J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010036 · Cited by 52
Deryabin, P. I., Shatrova, A. N., Marakhova, I. I., Nikolsky, N. N., & Borodkina, A. V. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03980-x · Cited by 46
González-Meljem, J. M., & Martínez-Barberá, J. P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03798-7 · Cited by 54
(2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000044 · Cited by 45
Macrophage Involvement in Aging-Associated Skeletal Muscle Regeneration
Cui, C., Ferrucci, L., & Gorospe, M. (2023) · Cells · doi:10.3390/cells12091214 · Cited by 53
“In agreement with these pleiotropic actions, removal of senescent cells delayed the onset of aging phenotypes but increased the incidence of tumorigenesis [146–148].”
BackgroundOxidative stress-induced senescence markedly increases disc cell bioenergetics
Patil, P. R., Falabella, M., Saeed, A., Lee, D., Kaufman, B. A., Shiva, S., Croix, C. M. S., Houten, B. V., Niedernhofer, L. J., Robbins, P. D., et al. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.04.006 · Cited by 47
The hallmarks of aging in Ataxia-Telangiectasia
Aguado, J., Gómez‐Inclán, C., Leeson, H. C., Lavin, M. F., Shiloh, Y., & Wolvetang, E. J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101653 · Cited by 49
Li, Y., Li, C., Zhou, Q., Liu, X., Qiao, Y., Xie, T., Sun, H., Ong, M. T., & Wang, H. (2025) · Nature Communications · doi:10.1038/s41467-025-61403-y · Cited by 73
Understanding the health effects of caregiving stress: New directions in molecular aging
Christian, L. M., Wilson, S. J., Madison, A. A., Prakash, R. S., Burd, C. E., Rosko, A. E., & Kiecolt‐Glaser, J. K. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102096 · Cited by 52
A tale of the good and bad: Cell senescence in bone homeostasis and disease
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.03.005 · Cited by 45
Gruendler, R., Hippe, B., Sendula Jengic, V., Peterlin, B., & Haslberger, A. G. (2020) · Molecules · doi:10.3390/molecules25246018 · Cited by 45
Elimination of p19ARF‐expressing cells protects against pulmonary emphysema in mice
Mikawa, R., Suzuki, Y., Baskoro, H., Kanayama, K., Sugimoto, K., Sato, T., & Sugimoto, M. (2018) · Aging Cell · doi:10.1111/acel.12827 · Cited by 45
Choi, S.-Y., Bin, B.-H., Kim, W., Lee, E., Lee, T. R., & Cho, E. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.02.016 · Cited by 55
Oncogenic senescence: a multi-functional perspective
Baker, D. J., Alimirah, F., van Deursen, J. M., Campisi, J., & Hildesheim, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15742 · Cited by 45
Self-citationThe role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Mechanisms involved in hematopoietic stem cell aging
Fujino, T., Asada, S., Goyama, S., & Kitamura, T. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04356-5 · Cited by 56
The quantum mitochondrion and optimal health
Nunn, A. V. W., Guy, G. W., & Bell, J. D. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160096 · Cited by 52
Zupan, J., Stražar, K., Kocijan, R., Nau, T., Grillari, J., & Marolt, D. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111539 · Cited by 60
Rizzo, M. G., Best, T. M., Huard, J., Philippon, M. J., Hornicek, F. J., Duan, Z., Griswold, A. J., Kaplan, L. D., Hare, J. M., & Kouroupis, D. (2023) · Cells · doi:10.3390/cells12101421 · Cited by 56
Arginase-II Deficiency Extends Lifespan in Mice
Xiong, Y., Yepuri, G., Montani, J., Ming, X., & Yang, Z. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00682 · Cited by 42
Distinct adipose progenitor cells emerging with age drive active adipogenesis
Wang, G., Li, G., Song, A., Zhao, Y., Yu, J., Wang, Y., Dai, W., Salas, M. C., Qin, H., Medrano, L. J., et al. (2025) · Science · doi:10.1126/science.adj0430 · Cited by 57
Kim, H., Jang, J., Song, M. J., Kim, G., Park, C.-H., Lee, D. H., Lee, S., & Chung, J. H. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18051 · Cited by 54
Inflammation and Ectopic Fat Deposition in the Aging Murine Liver Is Influenced by CCR2
Stahl, E. C., Delgado, E. R., Alencastro, F., LoPresti, S. T., Wilkinson, P. D., Roy, N., Haschak, M. J., Skillen, C. D., Monga, S. P., Duncan, A. W., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.10.016 · Cited by 50
Telomere attrition predicts reduced survival in a wild social bird, but short telomeres do not
Wood, E. M., & Young, A. J. (2019) · Molecular Ecology · doi:10.1111/mec.15181 · Cited by 45
Sharma, R. (2021) · Biogerontology · doi:10.1007/s10522-021-09936-9 · Cited by 55
Chu, L., Qu, Y.-X., An, Y., Hou, L., Li, J., Li, W., Fan, G., Song, B., Li, E., Zhang, L., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04601-6 · Cited by 52
Connecting chaperone-mediated autophagy dysfunction to cellular senescence
Moreno-Blas, D., Gorostieta-Salas, E., & Castro‐Obregón, S. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.11.001 · Cited by 46
Gurkar, A. U., Robinson, A. R., Cui, Y., Li, X., Allani, S. K., Webster, A., Muravia, M., Fallahi, M., Weissbach, H., Robbins, P. D., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.06.005 · Cited by 45
Urata, R., Ikeda, K., Yamazaki, E., Ueno, D., Katayama, A., Shin‐Ya, M., Ohgitani, E., Mazda, O., & Matoba, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-15976-z · Cited by 43
Clearance of p21 highly expressing senescent cells accelerates cutaneous wound healing
Gasek, N. S., Yan, P., Zhu, J., Purushothaman, K.-R., Kim, T., Wang, L., Wang, B., Flynn, W. F., Sun, M., Guo, C., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00755-4 · Cited by 43
Yu, S., Cheng, Y., Li, B., Xue, J., Yin, Y., Gao, J., Gong, Z., Wang, J., & Mu, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106294 · Cited by 46
Single-cell analysis of senescent epithelia reveals targetable mechanisms promoting fibrosis
O’Sullivan, E. D., Mylonas, K. J., Bell, R., Carvalho, C., Baird, D. P., Cairns, C., Gallagher, K. M., Campbell, R., Docherty, M., Laird, A., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.154124 · Cited by 43
Csík, B., Nyúl‐Tóth, Á., Gulej, R., Patai, R., Kiss, T., DelFavero, J., Nagaraja, R. Y., Balasubramanian, P., Shanmugarama, S., Ungvari, A., et al. (2025) · Aging Cell · doi:10.1111/acel.70048 · Cited by 57
“…the senescence marker p16 INK4A has shown notable improvements in lifespan, healthspan, microvascular function, and cognition (Faakye et al. 2023; Baker et al. 2016, 2011; Jeon et al. 2017; Abdul-Aziz et al. 2019; Kim et al. 2019; Patil et al. 2019; Farr et al. 2017; Xu et al. 2015; Roos et al.…”
Chemical Strategies for the Detection and Elimination of Senescent Cells
García-Fleitas, J., García‐Fernández, A., Martí‐Centelles, V., Sancenón, F., Bernardos, A., & Martínez‐Máñez, R. (2024) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00794 · Cited by 49
Pini, M., Czibik, G., Sawaki, D., Mezdari, Z., Braud, L., Delmont, T., Mercedes, R., Martel, C., Buron, N., Marcelin, G., et al. (2021) · Aging Cell · doi:10.1111/acel.13421 · Cited by 43
Cellular senescence: from anti-cancer weapon to anti-aging target
Yuan, L., Alexander, P. B., & Wang, X. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1629-6 · Cited by 43
Cellular senescence in tissue repair: every cloud has a silver lining
Yun, M. H. (2018) · The International Journal of Developmental Biology · doi:10.1387/ijdb.180081my · Cited by 41
Senescence and Immunoregulation in the Tumor Microenvironment
Ruhland, M. K., & Alspach, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.754069 · Cited by 52
Targeting Cellular Senescence for Age-Related Diseases: Path to Clinical Translation
Wyles, S. P., Tchkonia, T., & Kirkland, J. L. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009669 · Cited by 43
The Achilles’ heel of cancer survivors: fundamentals of accelerated cellular senescence
Shafqat, S., Arana‐Chicas, E., Shafqat, A., & Hashmi, S. K. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158452 · Cited by 46
The role of senolytics in osteoporosis and other skeletal pathologies
Doolittle, M. L., Monroe, D. G., Farr, J. N., & Khosla, S. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111565 · Cited by 47
Prevalent intron retention fine‐tunes gene expression and contributes to cellular senescence
Yao, J., Ding, D., Li, X., Shen, T., Fu, H., Zhong, J., Wei, G., & Ni, T. (2020) · Aging Cell · doi:10.1111/acel.13276 · Cited by 46
Self-citationThe Emerging Role of Accelerated Cellular Senescence in Periodontitis
Aquino-Martínez, R. (2023) · Journal of Dental Research · doi:10.1177/00220345231154567 · Cited by 45
“Removal of p16Ink4a-positive senescent cells delays tissue dysfunction and extends a healthy life span (Baker et al. 2011, 2016).”
BackgroundActivatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
Morsli, S., Doherty, G. J., & Muñoz-Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 42
Breathing new insights into the role of mutant p53 in lung cancer
Chen, T., Ashwood, L. M., Kondrashova, O., Strasser, A., Kelly, G., & Sutherland, K. D. (2025) · Oncogene · doi:10.1038/s41388-024-03219-6 · Cited by 46
The role of epithelial cells in fibrosis: Mechanisms and treatment
Luo, L., Zhang, W. Y., You, S., Cui, X. T., Tu, H., Qiao, Y., Wu, J., & Liu, O. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107144 · Cited by 50
Age-Related Changes in the Fibroblastic Differon of the Dermis: Role in Skin Aging
Zorina, A. I., Zorin, V. L., Kudlay, D. A., & Kopnin, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116135 · Cited by 51
Cellular senescence promotes cancer metastasis by enhancing soluble E-cadherin production
Kawaguchi, K., Komoda, K., Mikawa, R., Asai, A., & Sugimoto, M. (2021) · iScience · doi:10.1016/j.isci.2021.103022 · Cited by 44
Pan, C., Wang, X., Fan, Z., Mao, W., Shi, Y., Wu, Y., Liu, T., Xu, Z., Wang, H. H., & Chen, H. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.114888 · Cited by 49
Zheng, L., He, S., Wang, H., Li, J., Liu, Y., & Liu, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0206 · Cited by 83
“…suggests that excessive accumulation of SnCs in the body triggers tissue remodeling, organismal aging, etc., which ultimately leads to the development of age-related diseases, and that lifespan can be prolonged and age-associated diseases can be prevented or delayed by removing SnCs [10, 11].”
Mehdipour, M., Etienne, J., Chen, C.-C., Gathwala, R., Rehman, M., Kato, C., Liu, C., Liu, Y., Zuo, Y., Conboy, M. J., et al. (2019) · Aging · doi:10.18632/aging.102148 · Cited by 39
The role of extracellular vesicles in cellular senescence
Estévez‐Souto, V., Silva‐Álvarez, S. D., & Collado, M. (2022) · FEBS Journal · doi:10.1111/febs.16585 · Cited by 52
T lymphocyte senescence is attenuated in Parkinson’s disease
Kouli, A., Jensen, M. P., Papastavrou, V., Scott, K. M., Kolenda, C., Parker, C., Solim, I. H., Camacho, M., Martin-Ruiz, C. M., & Williams‐Gray, C. H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02287-9 · Cited by 48
Latorre, E., Ostler, E. L., Faragher, R., & Harries, L. W. (2018) · The FASEB Journal · doi:10.1096/fj.201801154r · Cited by 43
Lee, M. Y., Leonardi, A., Begley, T. J., & Melendez, J. A. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101375 · Cited by 44
Insights from In Vivo Studies of Cellular Senescence
Prieto, L. I., Graves, S. I., & Baker, D. J. (2020) · Cells · doi:10.3390/cells9040954 · Cited by 41
Self-citationTo stay young, kill zombie cells
Scudellari, M. (2017) · Nature · doi:10.1038/550448a · Cited by 46
Perturbation of METTL1-mediated tRNA N7- methylguanosine modification induces senescence and aging
Fu, Y., Jiang, F., Zhang, X., Pan, Y., Xu, R., Liang, X. H., Wu, X., Li, X., Lin, K., Shi, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49796-8 · Cited by 55
Molecular Signatures of Senescence in Periodontitis: Clinical Insights
Rattanaprukskul, K., Xia, X.-J., Jiang, M., Albuquerque‐Souza, E., Bandyopadhyay, D., & Sahingur, S. E. (2024) · Journal of Dental Research · doi:10.1177/00220345241255325 · Cited by 48
“The selective elimination of p16-express-ing cells expands the life span and improves clinical outcomes in several conditions such as pulmonary diseases, neuropathy, and osteoarthritis (Baker et al. 2016; Jeon et al. 2017; Acklin et al. 2020; Chaib et al. 2022; Kaur et al. 2023).”
BackgroundCellular mechanisms in brain aging: Focus on physiological and pathological aging
Aguilar‐Hernández, L., Alejandre‐Aguilar, R., Morales‐Medina, J. C., Iannitti, T., & Flores, G. (2022) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2022.102210 · Cited by 47
Hepatoprotective effects of hydroxysafflor yellow A in D-galactose-treated aging mice
Fei, M., Sun, H., Wang, B., Ahmad, N., Guo, H., Gao, H., Gao, Y., Liu, X., & Li, H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173214 · Cited by 44
Senolytic treatment modulates decidualization in human endometrial stromal cells
Kusama, K., Yamauchi, N., Yoshida, K., Azumi, M., Yoshie, M., & Tamura, K. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.07.075 · Cited by 44
Extracellular Vesicles, Ageing, and Therapeutic Interventions
Panagiotou, N., Neytchev, O., Selman, C., & Shiels, P. G. (2018) · Cells · doi:10.3390/cells7080110 · Cited by 45
Oda, T., Sekimoto, T., Kurashima, K., Fujimoto, M., Nakai, A., & Yamashita, T. (2018) · Journal of Cell Science · doi:10.1242/jcs.210724 · Cited by 44
Senescence of Tumor Cells in Anticancer Therapy—Beneficial and Detrimental Effects
Piskorz, W. M., & Cechowska‐Pasko, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911082 · Cited by 44
Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes
Griveau, A., Wiel, C., Calvé, B. L., Ziegler, D. V., Djebali, S., Warnier, M., Martin, N., Marvel, J., Vindrieux, D., Bergö, M. O., et al. (2018) · Aging Cell · doi:10.1111/acel.12835 · Cited by 44
Lorenzo, E. C., Torrance, B. L., Keilich, S. R., Al‐Naggar, I. M., Harrison, A. G., Xu, M., Bartley, J. M., & Haynes, L. (2021) · Aging Cell · doi:10.1111/acel.13525 · Cited by 50
Role of p53 in Regulating Radiation Responses
Okazaki, R. (2022) · Life · doi:10.3390/life12071099 · Cited by 46
PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA
Yano, K., Takahashi, R., Shiotani, B., Abe, J., Shidooka, T., Sudo, Y., Yamamoto, Y., Kan, S., Sakagami, H., & Tahara, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100882 · Cited by 47
An anti-inflammatory phenotype in visceral adipose tissue of old lean mice, augmented by exercise
Ziegler, A. K., Damgaard, A., Mackey, A. L., Schjerling, P., Magnusson, S. P., Olesen, A. T., Kjær, M., & Schéele, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-48587-2 · Cited by 45
Adipose Stromal Cell Expansion and Exhaustion: Mechanisms and Consequences
Eckel‐Mahan, K. L., Ribas‐Latre, A., & Kolonin, M. G. (2020) · Cells · doi:10.3390/cells9040863 · Cited by 42
Panneer Selvam, S., Roth, B. M., Nganga, R., Kim, J., Cooley, M. A., Helke, K., Smith, C. D., & Ogretmen, B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003506 · Cited by 40
Wang, X., Cai, Y., Wu, C., Liang, J., Tang, K., Lin, Z., Chen, L., Lu, Y., & Wang, Q. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02036-5 · Cited by 41
“p16ink4a is a cyclindependent kinase inhibitor that activates retinoblastoma-associated protein and induces cellular senescence [64], while the loss of nuclear HMGB-1 is considered a senescence biomarker [16, 44].”
BackgroundThe Role of Ageing and Parenchymal Senescence on Macrophage Function and Fibrosis
Campbell, R., Docherty, M.-H., Ferenbach, D. A., & Mylonas, K. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700790 · Cited by 47
Metabolic Alterations in Cellular Senescence: The Role of Citrate in Ageing and Age-Related Disease
Mycielska, M. E., James, E. N., & Parkinson, E. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073652 · Cited by 40
Li, N., Ye, Y., Wu, Y., Li, L., Hu, J., Luo, D., Li, Y., Yang, J., Gao, Y., Hai, W., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106571 · Cited by 54
“Although senescent cells may transiently exert beneficial effects, their chronic accumulation in various tissues and organs during aging has detrimental consequences.(43,49) In addition, the cellular microenvironment has also become an area of intense research.”
BackgroundTang, X., Deng, B., Zang, A., He, X., Zhou, Y., Wang, D., Li, D., Dai, X., Chen, J., Zhang, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940577 · Cited by 39
“Frontiers in Immunology 05 clearance of p16-positive cells delays this phenomenon (31).”
BackgroundBouvier, D. S., Fixemer, S., Heurtaux, T., Jeannelle, F., Frauenknecht, K. B. M., & Mittelbronn, M. G. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.814889 · Cited by 47
A guide to senolytic intervention in neurodegenerative disease
Lee, S., Wang, E. Y., Steinberg, A. B., Walton, C. C., Chinta, S. J., & Andersen, J. K. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111585 · Cited by 39
Franzin, R., Stasi, A., Ranieri, E., Netti, G. S., Cantaluppi, V., Gesualdo, L., Stallone, G., & Castellano, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.630419 · Cited by 42
Liu, P., Zhang, B., Li, Y., & Yuan, Q. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00842-7 · Cited by 46
“Two studies in mice have shown that cellular senescence, an irreversible blockage of cell proliferation, is feasible as a tumor suppression strategy (Baker et al. 2016; Demaria et al. 2017).”
BackgroundCardiac ageing: from hallmarks to therapeutic opportunities
Hastings, M. H., Zhou, Q., Wu, C., Shabani, P., Huang, S., Yu, X., Singh, A. P., Guseh, J. S., Li, H., Lerchenmüller, C., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae124 · Cited by 53
Senescent cells enhance newt limb regeneration by promoting muscle dedifferentiation
(2022) · doi:10.1101/2022.09.01.506186 · Cited by 39
Senescent cells enhance newt limb regeneration by promoting muscle dedifferentiation
Walters, H. E., Troyanovskiy, K. E., Graf, A. M., & Yun, M. H. (2023) · Aging Cell · doi:10.1111/acel.13826 · Cited by 39
“related disease progression (Baker et al., 2016; Bussian et al., 2018; Childs et al., 2016; Jeon et al., 2017), yet it can also promote wound healing (Demaria et al.”
Background
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.